Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 31-03-2025.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has submitted a routine regulatory compliance certificate for the January–March 2025 quarter. The certificate, issued by the company's Registrar and Share Transfer Agent (Bigshare Services Private Limited), confirms that all share certificates received from shareholders for dematerialization (conversion from physical to electronic form) up to March 31, 2025 were properly processed, confirmed with the depositories (NSDL/CDSL), and listed on the stock exchange. Physical certificates were cancelled after verification, and the depository's name was entered in the company's register of members within the 15-day deadline. This is a standard quarterly filing required by SEBI.
No material impact on shareholders or the stock price. This is a routine administrative compliance filing confirming proper handling of share dematerialization requests; investors can take it as a sign of good housekeeping and regulatory compliance.